エメダスチン

Emedastine

HCID 3219CAS 87233-61-2

基本情報

標準SMILES
CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21
InChIKey
KBUZBQVCBVDWKX-UHFFFAOYSA-N
分子式
C17H26N4O
平均分子量
302.4 g/mol
単同位体質量
302.21066145

概要

Emedastine is 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis. It has a role as a H1-receptor antagonist, an anti-allergic agent and an antipruritic drug.

名称と識別子

優先名称
Emedastine
IUPAC
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
現地名
エメダスチン
英語名
Emedastine
分子式
C17H26N4O
分子量
302.41

名称と別名

emedastine87233-61-2EmedastinaEmedastinum1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole9J1H7Y9OJV1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazoleCHEBI:4779DTXSID70482431-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-
名称をさらに表示
エメダスチン1-(2-エトキシエチル)-2-(4-メチルヘキサヒドロ-1H-1,4-ジアゼピン-1-イル)-1H-ベンゾイミダゾール1-(2-エトキシエチル)-2-[(ヘキサヒドロ-4-メチル-1H-1,4-ジアゼピン)-1-イル]-1H-ベンゾイミダゾール1-(2-エトキシエチル)-2-(4-メチル-1,4-ジアゼパン-1-イル)-1H-1,3-ベンゾジアゾールEmestineEmedastine impurity FEmedastinc Impurity CEmedastine Impurity CEmedastine Impurity 14Emedastine, 10 mM in DMSO1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole
KG 24131-(2-(ethoxy)ethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole1-(2-Ethoxy-ethyl)-2-(4-methyl-(1,4)diazepan-1-yl)-1H-benzoimidazoleRefChem:590745DTXCID8028218S01GX06Emedastine [INN]Emedastinum [INN-Latin]

データベース識別子

CAS
87233-61-2
PubChem CID
3219
DTXSID
DTXSID7048243
ChEMBL
CHEMBL594
ChEBI
CHEBI:4779
UNII
9J1H7Y9OJV
Nikkaji
J253.163A

物性

構造計算による物性

XLogP
2.2
極性表面積
33.5 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
5
重原子数
22

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LogP2.6
Solubility · 2 件

Soluble (difumarate formulation)

1.44e+00 g/L

Human Drugs · 2 件

Breast Feeding; Lactation; Milk, Human; Antihistamines

EMA approved medicines: Human medicine

Physical DescriptionSolid

物理化学的性質

沸点
446.6 · 446.6±55.0 °C(Predicted)
比重(密度)
1.15 · 1.15±0.1 g/cm3(Predicted)
貯蔵温度
2 · 2-8°C
溶解性
125 mg/mL · DMSO: 125 mg/mL (413.35 mM); Ethanol: 100 mg/mL (330.68 mM)
酸解離定数(Pka)
8.86 · 8.86±0.10(Predicted)
外見
Viscous Liquid

安全と法規制

毒性情報

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

化学と産業

薬理情報

ATC Code · 3 件

S01GX06

S - Sensory organs

QS - Sensory organs

PharmacodynamicsEmedastine is a relatively selective H<sub>1</sub>-receptor antagonist.
Mechanism of Action · 1 件

Emedastine is a relatively selective, histamine H<sub>1</sub> antagonist. In vitro examinations of emedastine's affinity for histamine receptors demonstrate relative selectivity for the H<sub>1</sub> histamine receptor. In vivo studies have shown concentration-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva following topical ocular administration. Emedastine appears exert negligible effects on adrenergic, dopaminergic and serotonin receptors.

Biological Half-LifeThe elimination half-life in the plasma is 3-4 hours following oral administration.
Metabolism/MetabolitesTwo primary metabolites, 5-hydroxyemedastine and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms. Minor metabolites include the 5'-oxoanalogs of 5-hydroxyemedastine and 6-hydroxy-emedastine and the N-oxide.
FDA Pharmacological Classification · 5 件

9J1H7Y9OJV

EMEDASTINE

Mechanisms of Action [MoA] - Histamine H1 Receptor Antagonists

Established Pharmacologic Class [EPC] - Histamine-1 Receptor Inhibitor

Emedastine is a Histamine-1 Receptor Inhibitor. The mechanism of action of emedastine is as a Histamine H1 Receptor Antagonist.

応用分野

用途ヒスタミンH 拮抗薬アレルギー性鼻炎,蕁麻疹,アトピー性皮膚炎

使用Antihistaminic, H1-receptor; asthma prophylactic; anti-allergic.

サプライヤー50 社

武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
广州佳途科技股份有限公司81960175 18933936954 · [email protected]
補足説明 · 1 件

定義ChEBI: 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the ifumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.

関連反応

10 件

関連ノート

読み込み中…